Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.

MILWAUKEE, April 2, 2024 /PRNewswire/ — Ademi LLP is investigating possible securities fraud claims against Akero (Nasdaq: AKRO). The investigation results from inaccurate statements Akero may have made regarding its business operations and prospects. Click here to learn more about the…